RNS Number : 7155E Renalytix PLC 03 July 2023       Renalytix plc ("Renalytix" or the "Company")   Directorate Change Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors   LONDON and SALT LAKE CITY -   July 3, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX), the

RNS Number : 5264E Renalytix PLC 30 June 2023       THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.   Renalytix plc ("Renalytix" or the "Company")   FDA Approves KidneyIntelX.dkd™   FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline

RNS Number : 7716C Renalytix PLC 15 June 2023     Renalytix plc ("Renalytix" or the "Company")   KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences Four new data presentations, including late breaking clinical study data,

RNS Number : 1817C Renalytix PLC 09 June 2023     Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023   LONDON and SALT LAKE CITY , June 9, 2023   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in

RNS Number : 1562C Renalytix PLC 08 June 2023       Renalytix plc    ("Renalytix" or the "Company")   Result of General Meeting   LONDON and SALT LAKE CITY , June 8, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that at the General Meeting (" GM ") held earlier today all resolutions

RNS Number : 5700B Renalytix PLC 05 June 2023       Renalytix plc    ("Renalytix" or the "Company")   Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9   LONDON and SALT LAKE CITY , June 5, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) will report its third quarter

RNS Number : 5773A Renalytix PLC 25 May 2023     Renalytix plc    ("Renalytix" or the "Company")   Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes   Model expected to accelerate deployment of

RNS Number : 1093A Renalytix PLC 22 May 2023     Renalytix plc    ("Renalytix" or the "Company")   Expansion of insurance coverage for KidneyIntelX TM   LONDON and SALT LAKE CITY , May 22, 2023 - Renalytix (NASDAQ: RNLX) (LSE: RENX) reports the expansion of insurance coverage for KidneyIntelX with

RNS Number : 0238Z Renalytix PLC 11 May 2023     Renalytix plc    ("Renalytix" or the "Company")   Notice of General Meeting and Posting of Circular   LONDON and SALT LAKE CITY , May 11, 2023 - Renalytix (NASDAQ: RNLX) (LSE: RENX) announces that a circular containing a notice convening a General

RNS Number : 6476W Renalytix PLC 19 April 2023     Renalytix plc    ("Renalytix" or the "Company")   New Published Real-World Evidence Shows KidneyIntelX™ Utility   Real-World Utility Data Demonstrates KidneyIntelX Optimizes Clinical Management in Early-Stage Chronic Kidney Disease Across Multiple